rs29281
Positions:
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_002024.6(FMR1):c.433G>T(p.Ala145Ser) variant causes a missense change. The variant allele was found at a frequency of 0.00499 in 1,191,575 control chromosomes in the GnomAD database, including 192 homozygotes. There are 1,528 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 11/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.025 ( 103 hom., 727 hem., cov: 22)
Exomes 𝑓: 0.0029 ( 89 hom. 801 hem. )
Consequence
FMR1
NM_002024.6 missense
NM_002024.6 missense
Scores
1
15
Clinical Significance
Conservation
PhyloP100: 4.97
Genes affected
FMR1 (HGNC:3775): (fragile X messenger ribonucleoprotein 1) The protein encoded by this gene binds RNA and is associated with polysomes. The encoded protein may be involved in mRNA trafficking from the nucleus to the cytoplasm. A trinucleotide repeat (CGG) in the 5' UTR is normally found at 6-53 copies, but an expansion to 55-230 repeats is the cause of fragile X syndrome. Expansion of the trinucleotide repeat may also cause one form of premature ovarian failure (POF1). Multiple alternatively spliced transcript variants that encode different protein isoforms and which are located in different cellular locations have been described for this gene. [provided by RefSeq, May 2010]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -20 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.0017594695).
BP6
Variant X-147929961-G-T is Benign according to our data. Variant chrX-147929961-G-T is described in ClinVar as [Benign]. Clinvar id is 129104.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.0854 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
FMR1 | NM_002024.6 | c.433G>T | p.Ala145Ser | missense_variant | 6/17 | ENST00000370475.9 | NP_002015.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
FMR1 | ENST00000370475.9 | c.433G>T | p.Ala145Ser | missense_variant | 6/17 | 1 | NM_002024.6 | ENSP00000359506.5 |
Frequencies
GnomAD3 genomes AF: 0.0254 AC: 2820AN: 110893Hom.: 103 Cov.: 22 AF XY: 0.0217 AC XY: 721AN XY: 33203
GnomAD3 genomes
AF:
AC:
2820
AN:
110893
Hom.:
Cov.:
22
AF XY:
AC XY:
721
AN XY:
33203
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00772 AC: 1396AN: 180837Hom.: 48 AF XY: 0.00445 AC XY: 293AN XY: 65783
GnomAD3 exomes
AF:
AC:
1396
AN:
180837
Hom.:
AF XY:
AC XY:
293
AN XY:
65783
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00289 AC: 3122AN: 1080631Hom.: 89 Cov.: 28 AF XY: 0.00230 AC XY: 801AN XY: 348921
GnomAD4 exome
AF:
AC:
3122
AN:
1080631
Hom.:
Cov.:
28
AF XY:
AC XY:
801
AN XY:
348921
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0255 AC: 2826AN: 110944Hom.: 103 Cov.: 22 AF XY: 0.0219 AC XY: 727AN XY: 33264
GnomAD4 genome
AF:
AC:
2826
AN:
110944
Hom.:
Cov.:
22
AF XY:
AC XY:
727
AN XY:
33264
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
TwinsUK
AF:
AC:
2
ALSPAC
AF:
AC:
1
ESP6500AA
AF:
AC:
353
ESP6500EA
AF:
AC:
3
ExAC
AF:
AC:
1032
ClinVar
Significance: Benign
Submissions summary: Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not specified Benign:2
Likely benign, no assertion criteria provided | clinical testing | Genetic Services Laboratory, University of Chicago | - | Likely benign based on allele frequency in 1000 Genomes Project or ESP global frequency and its presence in a patient with a rare or unrelated disease phenotype. NOT Sanger confirmed. - |
Benign, criteria provided, single submitter | clinical testing | Eurofins Ntd Llc (ga) | Mar 26, 2018 | - - |
Inborn genetic diseases Benign:1
Benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 24, 2014 | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Fragile X syndrome Benign:1
Benign, no assertion criteria provided | clinical testing | Natera, Inc. | Sep 16, 2020 | - - |
not provided Benign:1
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Fragile X syndrome;C1839780:Fragile X-associated tremor/ataxia syndrome;C4552079:Premature ovarian failure 1 Benign:1
Benign, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | Apr 12, 2022 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
DEOGEN2
Benign
T;.;.;.;.;T;T;.;T;T;T;.
FATHMM_MKL
Benign
N
LIST_S2
Benign
T;T;T;T;T;T;.;T;T;T;T;T
MetaRNN
Benign
T;T;T;T;T;T;T;T;T;T;T;T
MetaSVM
Benign
T
MutationAssessor
Benign
.;N;N;N;.;.;.;.;N;.;.;N
PrimateAI
Uncertain
T
PROVEAN
Benign
.;N;N;.;N;.;N;N;N;.;.;N
REVEL
Benign
Sift
Benign
.;T;T;.;T;.;T;T;T;.;.;T
Sift4G
Benign
T;T;T;T;T;T;T;T;T;T;T;T
Polyphen
0.0
.;.;.;B;.;B;B;B;B;.;.;.
Vest4
MVP
MPC
0.81
ClinPred
T
GERP RS
RBP_binding_hub_radar
RBP_regulation_power_radar
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at